Evidence map›Paper›PMID 26324702›Full record

ArticleBlood2015

Rap1 and its effector RIAM are required for lymphocyte trafficking.

Wenjuan Su, Joseph Wynne, Elaine M Pinheiro, Marianne Strazza, Adam Mor, Emilie Montenont, Jeffrey Berger, David S Paul, Wolfgang Bergmeier, Frank B Gertler and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 79 citations in OpenAlex.

  1. Platelet Membrane Receptors and Signalling Pathways.Handbook of experimental pharmacology · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Talin‑1 interaction network in cellular mechanotransduction (Review).International journal of molecular medicine · 2022
    Review
  15. Review
  16. Article
  17. Review
  18. Expression of the phagocytic receptors αFrontiers in immunology · 2022
    Article
  19. Article
  20. Initiation of focal adhesion assembly by talin and kindlin: A dynamic view.Protein science : a publication of the Protein Society · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Wenjuan SuPerlmutter Cancer Institute and.
Joseph WynneDepartment of Medicine, University of Chicago, Chicago, IL;
Elaine M PinheiroImmune Modulatory Receptor/Oncology, Merck Research Laboratories, Boston, MA;
Marianne StrazzaDepartment of Medicine, New York University School of Medicine, New York, NY;
Adam MorDepartment of Medicine, New York University School of Medicine, New York, NY;
Emilie MontenontDepartment of Medicine, New York University School of Medicine, New York, NY;
Jeffrey BergerDepartment of Medicine, New York University School of Medicine, New York, NY;
David S PaulMcAllister Heart Institute and.
Wolfgang BergmeierMcAllister Heart Institute and Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, NC; and.
Frank B GertlerKoch Institute, Massachusetts Institute of Technology, Cambridge, MA.
Mark R PhilipsPerlmutter Cancer Institute and Department of Medicine, New York University School of Medicine, New York, NY;ORCID http://orcid.org/0000-0002-1179-8156
New York University · USCancer Institute (WIA) · INMassachusetts Institute of Technology · USMerck & Co., Inc., Rahway, NJ, USA (United States) · USUniversity of Chicago · USUniversity of North Carolina at Chapel Hill · US

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI MATTHEW G. VANDER HEIDEN · 1985 to 2026
$93.9M
Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
Tumor Cell Networks CenterU54CA112967 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LAUFFENBURGER, DOUGLAS A · 2004 to 2015
$26.2M
MEDICAL SCIENTIST TRAININGT32GM007308 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PHILIPS, MARK REID · 1985 to 2019
$23.2M
Thrombosis Models CoreP01HL120846 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI ABRAMS, CHARLES S. · 2014 to 2018
$12.2M
RESEARCH IN THE PATHOGENESIS OF HEMATOLOGIC DISORDERST32HL007151 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI AL-HOMSI, AHMAD SAMER · 1988 to 2018
$5.9M
CELLULAR AND DEVELOPMENTAL FUNCTIONS OF MENAR01GM058801 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GERTLER, FRANK B · 1999 to 2012
$3.8M
Membrane Targeting of GTPasesR01GM055279 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PHILIPS, MARK REID · 1997 to 2010
$3.2M
Spatial regulation of platelet activation by Podoplanin-Clec2 signalingR01HL121650 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI BERGMEIER, WOLFGANG, KAHN, MARK L · 2014 to 2017
$1.2M
NCI NIH HHS P30 CA014051NCI NIH HHS P30 CA016087NCI NIH HHS P30-CA016087NCI NIH HHS P30-CA14051NCI NIH HHS U54 CA112967NCI NIH HHS U54-CA112967NHLBI NIH HHS P01 HL120846NHLBI NIH HHS P01-HL120846NHLBI NIH HHS R01 HL121650NHLBI NIH HHS T32 HL007151NIGMS NIH HHS GM055279NIGMS NIH HHS GM58801NIGMS NIH HHS R01 GM055279NIGMS NIH HHS R01 GM058801NIGMS NIH HHS T32 GM007308NIGMS NIH HHS T32-GM007308
6 · The paper itself

Abstract

Regulation of integrins is critical for lymphocyte adhesion to endothelium and trafficking through secondary lymphoid organs. Inside-out signaling to integrins is mediated by the small GTPase Rap1. Two effectors of Rap1 regulate integrins, RapL and Rap1 interacting adaptor molecule (RIAM). Using mice conditionally deficient in both Rap1a and Rap1b and mice null for RIAM, we show that the Rap1/RIAM module is not required for T- or B-cell development but is essential for efficient adhesion to intercellular adhesion molecule (ICAM) 1 and vascular cell adhesion molecule (VCAM) 1 and for proper trafficking of lymphocytes to secondary lymphoid organs. Interestingly, in RIAM-deficient mice, whereas peripheral lymph nodes (pLNs) were depleted of both B and T cells and recirculating B cells were diminished in the bone barrow (BM), the spleen was hypercellular, albeit with a relative deficiency of marginal zone B cells. The abnormality in lymphocyte trafficking was accompanied by defective humoral immunity to T-cell-dependent antigens. Platelet function was intact in RIAM-deficient animals. These in vivo results confirm a role for RIAM in the regulation of some, but not all, leukocyte integrins and suggest that RIAM-regulated integrin activation is required for trafficking of lymphocytes from blood into pLNs and BM, where relatively high shear forces exist in high endothelial venules and sinusoids, respectively.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsB-LymphocytesCell AdhesionChemotaxis, LeukocyteIntegrinsMembrane ProteinsMiceMice, Knockoutrap1 GTP-Binding ProteinsT-LymphocytesAdaptor Proteins, Signal TransducingIntegrinsMembrane Proteinsrap1 GTP-Binding ProteinsRIAM protein, mouse

Identifiers

PMID26324702
PMCPMC4683330
OpenAlexW1262336387

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.